The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|November 1, 2012
- Pharmaceutical Technology-11-01-2012
- Volume 2012 Supplement
- Issue 6
Pharmaceutical Technology, Analytical Supplement 2012 (PDF)
Analytical and Bioanalytical Testing
Advertisement
Articles in this issue
about 14 years ago
Moisture Matters in Lyophilized Drug Productabout 14 years ago
A Novel Process for Developing Fully Human Monoclonal Antibodiesabout 14 years ago
Improving Technology Transferabout 14 years ago
Analytical Applicationsabout 14 years ago
Using a Systematic Approach to Select Critical Process Parametersabout 14 years ago
Nuclear Magnetic Resonance as a Bioprocessing QbD ApplicationAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement